9F1A
Crystal structure of human soluble epoxide hydrolase C-terminal domain in complex with a benzohomoadamantane-based urea inhibitor
This is a non-PDB format compatible entry.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I24 |
Synchrotron site | Diamond |
Beamline | I24 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2023-11-17 |
Detector | DECTRIS PILATUS3 6M |
Wavelength(s) | 0.9999 |
Spacegroup name | I 1 2 1 |
Unit cell lengths | 93.019, 81.756, 108.112 |
Unit cell angles | 90.00, 90.54, 90.00 |
Refinement procedure
Resolution | 70.840 - 2.800 |
R-factor | 0.2241 |
Rwork | 0.220 |
R-free | 0.29220 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.011 |
RMSD bond angle | 1.448 |
Data reduction software | xia2 |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX (1.20.1_4487) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 70.840 | 2.900 |
High resolution limit [Å] | 2.800 | 2.800 |
Number of reflections | 20104 | 2001 |
<I/σ(I)> | 7.07 | |
Completeness [%] | 98.0 | |
Redundancy | 2 | |
CC(1/2) | 0.903 | 0.594 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 7.4 | 277.15 | 20% PEG 3350, 0.2 M malic acid, 0.05 M HEPES, 10% Ethylene Glycol |